Christopher Adams, PharmD, RPh, BCPS

home / authors / christopher-adams-pharmd-rph-bcps

Articles

Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?

Christopher Adams, PharmD, RPh, BCPS;Andrea R. Resseguie, PharmD, RPh, CACP

January 18th 2016

Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.

A New Direction in Reversal

Christopher Adams, PharmD, RPh, BCPS;Andrea R. Resseguie, PharmD, RPh, CACP

August 11th 2015

Target-specific oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban are now being used in a larger and more diverse patient population.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders

Published: January 18th 2016 | Updated: October 18th 2024

10 Pharmacy Quotes That Will Make You Rethink the Profession

Published: September 22nd 2015 | Updated: October 14th 2024

Gabapentin Differs From Pregabalin in Several Key Ways

Published: August 30th 2024 | Updated: November 21st 2024

Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report

Published: October 8th 2024 | Updated: November 21st 2024

What Drug Rates Are Reported in Price Transparency Data?

Image Credit: Syda Productions - stock.adobe.com

Published: October 7th 2024 | Updated: November 21st 2024

What Went Wrong: How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Christopher Adams, PharmD, RPh, BCPS

Articles

Latest Updated Articles